Pilihan
Geneva College of Longevity Science Launches the World's First PhD in Longevity Sciences
GENEVA and CONSTANȚA, Romania, April 24, 2026 (GLOBE NEWSWIRE) -- The Geneva College of Longevity Science (GCLS) today announced the launch of the world’s first PhD in Medicine with a specialization in Longevity Sciences, developed in academic partnership with Ovidius University of Constanța.
The four-year doctoral program represents a major milestone in the evolution of longevity science, designed to train a new generation of physician-scientists and researchers focused on preventive, healthspan-oriented healthcare and the clinical translation of aging biology.
“Longevity medicine has reached a point where the science is advancing faster than the institutions required to translate it responsibly into healthcare,” said Dominik Thor, President of GCLS. “With this PhD, we are building the academic and research infrastructure needed to support the field’s long-term development.”
From Emerging Science to Medical Discipline
Advances in aging biology, genomics, and digital health have created new opportunities to move beyond reactive care toward proactive risk management and healthspan preservation. Despite this progress, formal academic pathways in longevity science have remained limited.
The PhD in Longevity Sciences addresses this gap by providing structured doctoral training in:
Biology of aging and longevity pathways
Biomarkers and measurement of biological age
Preventive, risk-stratified, and healthspan-oriented medicine
Epidemiology of aging populations
Ethical, regulatory, and health system considerations
The program reflects a broader shift in medicine - from treating disease after onset to addressing the underlying drivers of disease across the lifespan - and is grounded in evidence-based medicine.
By embedding longevity science within a formal doctoral framework, GCLS and Ovidius University aim to:
Support the development of evidence-based longevity medicine
Train researchers capable of translating science into clinical practice
Contribute to sustainable, prevention-focused healthcare systems
Establish academic standards in an emerging global field
Applications Now Open
The program is designed for graduates with a strong academic background and a research interest in aging biology, preventive medicine, or related fields.
More information and application details:
https://www.gcls.study/phd-programme
About Geneva College of Longevity Science (GCLS)
The Geneva College of Longevity Science (GCLS) is a Swiss-based higher education institute dedicated to longevity science, preventive medicine, and the clinical translation of aging biology into evidence-based healthcare practice.
Learn more: https://www.gcls.study
Press Contact
Geneva College of Longevity Science (GCLS)
Email: press@gcls.study
Website: https://gcls.ai
Copyright 2026 GlobeNewswire, Inc.
.png)

Berita Lainnya
Countdown Appoints Julie Teer as Chief Executive Officer
Sigenergy Secures Over 20 GWh in Global Energy Storage Agreements at Intersolar Europe 2026
Laporan Bitget UEX: Investor Ritel Beralih dari Kripto karena 52% Menambah Saham dan 51% Menggunakan AI
Curium Announces Definitive Agreement to Merge with Lantheus
Robot Humanoid Booster Robotics Menyabet Seluruh Gelar Juara di Ajang RoboCup 2026
`IPC Systems' Emissions Reduction Targets Validated by the Science Based Targets Initiative
SiriusPoint Reports Second Quarter 2026 Net Income of $69m, Return on Equity of 12.0% and Operating Return on Equity of 13.8%
Framery mengumumkan lini produk Gradus baru yang didesain untuk pasar AS dan Kanada
Teva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus (ocrelizumab) for Multiple Sclerosis
Moment Factory dan Mitsui Fudosan Menjalin Kemitraan Strategis Jangka Panjang untuk Menghadirkan Pengalaman Inovatif bagi Para Penggemar.
Bitget Launches Fixed Coupon Notes for US Stock rTokens
Caseware Launches Global 30 Under 30 Excellence Network, Building on the Momentum of the Caseware Verity Launch